News
-
23 November 2020
Molecular roadmap of coronavirus
Scientists have presented an extensive molecular roadmap of the coronavirus: the COVID-19 Disease Map. This map sets out all the interactions between the virus and human cells that are known to date. In total, there are 1836 such interactions. This knowledge helps researchers in further unravelling...
-
2 November 2020
Study to explore risk factors associated with chronic complaints after COVID-19
Researchers at Maastricht UMC+ and Maastricht University are to investigate which factors play a role in long-term health complaints after COVID-19 and which patients may be susceptible to developing chronic complaints. The Maastricht researchers will do so as a partner in the Dutch Precision...
-
21 October 2020
Stem cells protect brain during preterm birth
A specific type of stem cell can protect an important area of the brain from the damaging effects of oxygen deprivation during preterm birth. That is the conclusion of a recent preclinical study carried out by researchers at the Department of Paediatrics, Maastricht UMC+. The researchers have...
-
15 October 2020
Cognitive behavioural therapy for pain after breast cancer surgery
Medical specialists at Maastricht UMC+ will collaborate with the Faculty of Psychology and Neuroscience at Maastricht University to investigate whether cognitive behavioural therapy can help prevent persistent pain after breast cancer treatment, a problem that affects about four out of ten patients...
-
30 September 2020
Treating arteriosclerosis and cardiac arrhythmia in a single operation
Thanks to a new method, patients of Maastricht UMC+ can be treated in one single operation for vascular disorders (arteriosclerosis) and heart arrhythmia. This is done by making just a couple of small incisions in the chest. The patient is spared a second operation and in addition, this form of...
-
4 September 2020
Early treatment of atrial fibrillation means fewer complications later
Early treatment of chronic arrhythmia reduces the risk of serious cardiovascular complications and death, unlike the current standard protocol of merely monitoring and managing symptoms. These are the conclusions that a team of international researchers will publish today in the prestigious New...
-
31 August 2020
World Congress on regenerative medicine comes to Maastricht
The 6th World Congress of the Tissue Engineering and Regenerative Medicine International Society (TERMIS) will take place at the Maastricht Exhibition & Congress Center (MECC) from 31 May to 4 June 2021. This prestigious congress will proceed even if the coronavirus restrictions remain in place...
-
27 August 2020
Nearly three-quarters of patients seizure-free after epilepsy surgery
A large-scale European study on the effectiveness of epilepsy surgery convincingly demonstrates the success of such interventions. These results help in deciding whether an operation is useful in the case of epilepsy. The findings also underpin the idea that operating as quickly as possible...
-
10 August 2020
Analgesic 'bee' gives relief to dialysis patients
A small device shaped like a bee is easing the pain of repeated needle pricks in dialysis patients. This offers a solution in particular for people with a needle phobia. The handy little device is already being used with young patients on the paediatric ward, but Maastricht UMC+ is now introducing...
-
30 July 2020
European grant for developing innovative cancer drug
Scientists at Maastricht UMC+ and Maastro irradiation clinic have received a 150,000 euro grant from the European Research Council to help them bring an innovative cancer drug a step closer to being available to patients. The Maastricht researchers have their eyes on two promising substances that...
